Stefan Oelrich has been a member of the Board of Management of Bayer AG and head of the Pharmaceuticals Division since 2018. Since 2016, Oelrich has been a member of the Supervisory Board of the Berlin Institute of Health. He held several positions in the health care business in Latin America, Europe and the United States over the first twenty years of his career. Between 2003 and 2005, he was Vice President of Marketing at Pharmaceuticals in the United States, before being appointed President of Healthcare and Diagnostics in France. In 2006, Oelrichworked in the United States as Senior Vice President and General Manager of Women’s Healthcare, before joining Sanofi in 2011 as General Manager in Germany, Switzerland and Austria. He then became head of Sanofi’s Diabetes and Cardiovascular business unit in Europeand Europe Coordinator. Prior to his current role, Oelrich was head of Sanofi’s global diabetes franchise and was appointed Executive Vice President Diabetes & Cardiovascular on the Executive Committee of Sanofi.
